Baxter International Inc vs Mondaycom Ltd — how do they compare? Baxter International Inc trades at $27.11 (market cap $14.27B), while Mondaycom Ltd trades at $84.49 (market cap $3.70B). The key difference: Baxter International Inc is far larger — about 3.9× Mondaycom Ltd's market cap, and Baxter International Inc pays a 0.14% dividend while Mondaycom Ltd pays none. Which is the better fit depends on your goals.
| BAX | MNDY | |
|---|---|---|
Market Cap | $14.27B | $3.70B |
Sector | Health | Technology |
52-Week High | $28.35 | $219.15 |
52-Week Low | $15.80 | $58.81 |
Enterprise Value | $21.79B | $2.86B |
Dividend Yield | 0.14% | — |
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $27.09, down 2.48% today but showing strong technical momentum with bullish moving averages and recent earnings beats. The company reported Q2 2026 EPS of $0.56, beating expectations by 53%, and raised full-year guidance. Despite negative net margins and elevated P/E ratio of 87.85, improving operational performance and positive cash flow projections for 2026 suggest potential turnaround.
The stock presents a mixed outlook with strong technical momentum and recent operational improvements offset by valuation concerns and profitability challenges. Key opportunities include continued execution on raised guidance and debt reduction efforts, while risks center on margin pressure and high debt levels. Analyst consensus leans neutral with 55.55% hold ratings and $25.43 price target below current levels.
Monday.com (MNDY) trades at $84.4, down 4.76% amid mixed signals. The stock shows strong fundamentals with Q2 2026 EPS of $1.48 beating estimates by 33%, revenue growth of 22% year-over-year, and a high gross margin of 88.74%. However, weak Q3 revenue guidance has triggered a sell-off. Technical indicators are neutral with support at $83 and resistance at $89. Analyst consensus remains bullish with a $113.38 price target, but near-term volatility persists due to growth concerns.
The outlook is cautiously optimistic given solid earnings beats and AI product traction, but investor sentiment is tempered by slowing revenue guidance. Key risks include SaaS sector pressures and execution challenges in shifting to enterprise AI. Upside potential exists if the company exceeds Q3 expectations, though volatility may continue until growth reaccelerates.
Trailing returns across standard periods
Latest headlines on both assets
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →